<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>INTRODUCTION: The goal was to develop an in-house serological method with high specificity and sensitivity for diagnosis and monitoring of <z:e sem="disease" ids="C0041234" disease_type="Disease or Syndrome" abbrv="">Chagas disease</z:e> morbidity </plain></SENT>
<SENT sid="1" pm="."><plain>METHODS: With this purpose, the reactivities of anti-T. cruzi IgG and subclasses were tested in successive serum dilutions of patients from Berilo municipality, Jequitinhonha Valley, Minas Gerais, Brazil </plain></SENT>
<SENT sid="2" pm="."><plain>The performance of the in-house ELISA was also evaluated in samples from other relevant <z:e sem="disease" ids="C0009450" disease_type="Disease or Syndrome" abbrv="">infectious diseases</z:e>, including HIV, <z:hpo ids='HP_0012115'>hepatitis</z:hpo> C (HCV), <z:e sem="disease" ids="C0039128" disease_type="Disease or Syndrome" abbrv="">syphilis</z:e> (SYP), <z:e sem="disease" ids="C0023290" disease_type="Disease or Syndrome" abbrv="">visceral leishmaniasis</z:e> (VL), and American tegumentary <z:e sem="disease" ids="C0023281" disease_type="Disease or Syndrome" abbrv="">leishmaniasis</z:e> (ATL), and noninfected controls (NI) </plain></SENT>
<SENT sid="3" pm="."><plain>Further analysis was performed to evaluate the applicability of this in-house methodology for monitoring <z:e sem="disease" ids="C0041234" disease_type="Disease or Syndrome" abbrv="">Chagas disease</z:e> morbidity into three groups of patients: indeterminate (IND), cardiac (CARD), and digestive/mixed (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DIG</z:e>/Mix), based on their clinical status </plain></SENT>
<SENT sid="4" pm="."><plain>RESULTS: The analysis of total IgG reactivity at serum dilution 1:40 was an excellent approach to <z:e sem="disease" ids="C0041234" disease_type="Disease or Syndrome" abbrv="">Chagas disease</z:e> diagnosis (100% sensitivity and specificity) </plain></SENT>
<SENT sid="5" pm="."><plain>The analysis of IgG subclasses showed cross-reactivity, mainly with NI, VL, and ATL, at <z:hpo ids='HP_0000001'>all</z:hpo> selected serum dilutions </plain></SENT>
<SENT sid="6" pm="."><plain>Based on the data analysis, the IND group displayed higher IgG3 levels and the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">DIG</z:e>/Mix group presented higher levels of total IgG as compared with the IND and CARD groups </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: These findings demonstrated that methodology presents promising applicability in the analysis of anti-T. cruzi IgG reactivity for the differential diagnosis and evaluation of <z:e sem="disease" ids="C0041234" disease_type="Disease or Syndrome" abbrv="">Chagas disease</z:e> morbidity </plain></SENT>
</text></document>